Objectives: Acute lymphoblastic leukemia (ALL) treatment is changing rapidly as immunotherapy, targeted drugs, and measurable residual disease (MRD) testing move into routine care. This review summarizes major therapeutic advances reported between 2019 and 2026.
Methods: This SANRA-informed narrative review synthesized...
Karolina Skórka, Oliwia Żmuda, Natalia Skórka et al.· International Journal of Inn...· 0 citations
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can overlap clinically and radiologically with pediatric-onset multiple sclerosis (MS). Transient cerebrospinal fluid (CSF) oligoclonal bands (OCBs), which may substitute for dissemination in time under the 2017 McDonald criteria, can c...
B. Wójtowicz, Oliwia Żmuda, Szymon Skrzypek et al.· International Journal of Inn...· 0 citations
A testable integrative model in which microvascular injury, blood-brain barrier disruption and neuroinflammation may contribute to persistent cognitive symptoms in PCS is outlined, as current data are largely cross-sectional and derive partly from in vitro work.
Szymon Skrzypek, Natalia Skórka, B. Wójtowicz et al.· 0 citations
This review argues for a shift from antibody-driven testing ("test when encephalitis is suspected") to syndrome-driven testing ("epilepsy-plus" phenotypes triggering a reflex panel), proposing a risk-stratified, treat-to-remission framework.
Szymon Skrzypek, Oliwia Żmuda, Natalia Skórka et al.· International Journal of Inn...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.